PMDA inspection
Novartis Pharmaceutical Manufacturing GmbH - Betriebssta( ̈)tte / Manufacturing Site Kundl
PMDA inspection 5130408025231 · Austria · Suitable
Key facts
| Control number | 5130408025231 |
|---|---|
| Manufacturing site | Novartis Pharmaceutical Manufacturing GmbH - Betriebssta( ̈)tte / Manufacturing Site Kundl |
| Location | Biochemiestrasse 10, 6250 Kundl, Austria |
| Country | Austria |
| Product type | Pharmaceuticals |
| Application type | Regular |
| Inspection method | Remote |
| Inspection month | Nov 1, 2024 |
| Result | Suitable |
| Result notified | Nov 19, 2024 |
| PMDA registration | AG22500032 |
About PMDA GMP inspections (Japan)
Japan's PMDA conducts GMP and QMS inspections of domestic and foreign manufacturing sites that supply the Japanese market.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan